{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:29:29Z","timestamp":1790792969599,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.nbt.2017.07.010","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T14:32:15Z","timestamp":1501597935000},"page":"174-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":290,"special_numbering":"PB","title":["Production of virus-like particles for vaccines"],"prefix":"10.1016","volume":"39","author":[{"given":"J.","family":"Fuenmayor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"G\u00f2dia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2017.07.010_bib0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nbt1261","article-title":"Vaccine manufacturing: challenges and solutions","volume":"24","author":"Ulmer","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-6445(99)00025-X","article-title":"Vaccines, coming of age after 200 years","volume":"24","author":"M\u00e4kel\u00e4","year":"2000","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.nbt.2017.07.010_bib0015","first-page":"1","article-title":"History of vaccination","volume":"2014","author":"Plotkin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nbt.2017.07.010_bib0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/infdis\/jiu648","article-title":"Raising expectations for subunit vaccine","volume":"211","author":"Schiller","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nbt.2017.07.010_bib0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2796.2003.01140.x","article-title":"REVIEW DNA vaccines: a review","volume":"253","author":"Liu","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.nbt.2017.07.010_bib0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nbt.2017.07.010_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/bit.25159","article-title":"Bioengineering virus-like particles as vaccines","volume":"111","author":"Lua","year":"2014","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nbt.2017.07.010_bib0040","first-page":"891","article-title":"Human papillomavirus type16- L1 VLP production in insect cells","volume":"16","author":"Abdoli","year":"2013","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.nbt.2017.07.010_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jbiotec.2013.05.001","article-title":"Generation of HIV-1 Gag VLPs by transient transfection of HEK 293 suspension cell cultures using an optimized animal-derived component free medium","volume":"166","author":"Cervera","year":"2013","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pep.2013.05.009","article-title":"Use of baculovirus expression system for generation of virus-like particles: successes and challenges","volume":"90","author":"Liu","year":"2013","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.nbt.2017.07.010_bib0055","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.vaccine.2016.02.047","article-title":"Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B","volume":"34","author":"Hu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0060","doi-asserted-by":"crossref","first-page":"10415","DOI":"10.1007\/s00253-015-7000-8","article-title":"The application of virus-like particles as vaccines and biological vehicles","volume":"99","author":"Yan","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0065","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1128\/AEM.72.1.745-752.2006","article-title":"Production of human papillomavirus type 16 L1 virus-Like particles by recombinant lactobacillus casei cells production of human papillomavirus type 16 L1 virus-Like particles by recombinant lactobacillus casei cells","volume":"72","author":"Aires","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jmv.20228","article-title":"E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability","volume":"74","author":"Tan","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004782","article-title":"Expression and characterization of yeast derived chikungunya virus like particles (CHIK-VLPs) and its evaluation as a potential vaccine candidate","volume":"10","author":"Saraswat","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nbt.2017.07.010_bib0080","first-page":"8","article-title":"Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil\u2122 in adult women","author":"Luna","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbt.2017.07.010_bib0085","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/biot.201400438","article-title":"The baculovirus expression vector system: a commercial manufacturing platform for viral vaccines and gene therapy vectors","volume":"10","author":"Felberbaum","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.nbt.2017.07.010_bib0090","first-page":"7","article-title":"Effective chikungunya virus-like particle vaccine produced in insect cells","author":"Metz","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.nbt.2017.07.010_bib0095","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1128\/JVI.00050-06","article-title":"Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses","volume":"80","author":"Buonaguro","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bit.10773","article-title":"Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system","volume":"84","author":"Maranga","year":"2003","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nbt.2017.07.010_bib0105","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1128\/JVI.07164-11","article-title":"HIV-1 virus-like particles produced by stably transfected drosophila S2Cells: a desirable vaccine component","volume":"86","author":"Yang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0110","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2007.02.059","article-title":"Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza","volume":"25","author":"Pushko","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jbiotec.2013.11.018","article-title":"Virus-free transient protein production in Sf9 cells","volume":"171","author":"Shen","year":"2013","journal-title":"J Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0120","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biotechadv.2011.08.022","article-title":"Mammalian cell protein expression for biopharmaceutical production","volume":"30","author":"Zhu","year":"2012","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.nbt.2017.07.010_bib0125","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nbt1026","article-title":"Production of recombinant protein therapeutics in cultivated mammalian cells","volume":"22","author":"Wurm","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0130","first-page":"40","article-title":"Recombinant protein therapeutics from CHO cells \u2014 20 years and counting","author":"Jayapal","year":"2007","journal-title":"CEP Mag"},{"key":"10.1016\/j.nbt.2017.07.010_bib0135","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1016\/j.vaccine.2010.04.025","article-title":"Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL\/6 mice","volume":"28","author":"Li","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0140","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.vaccine.2015.03.088","article-title":"Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate","volume":"33","author":"Fontana","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-10-141","article-title":"Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches","volume":"10","author":"Thompson","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.nbt.2017.07.010_bib0150","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1007\/s00253-015-7213-x","article-title":"Optimized production of HIV-1 virus-like particles by transient transfection in CAP-T cells","volume":"100","author":"Guti\u00e9rrez-Granados","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0155","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrg1177","article-title":"The production of recombinant pharmaceutical proteins in plants","volume":"4","author":"JK-C","year":"2003","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.nbt.2017.07.010_bib0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/abbs\/37.3.153","article-title":"Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants","volume":"37","author":"Liu","year":"2005","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.nbt.2017.07.010_bib0165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1467-7652.2009.00496.x","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza","volume":"8","author":"D\u2019Aoust","year":"2010","journal-title":"Plant Biotechnol J"},{"key":"10.1016\/j.nbt.2017.07.010_bib0170","doi-asserted-by":"crossref","first-page":"8228","DOI":"10.1016\/j.vaccine.2007.09.061","article-title":"Production of recombinant HIV-1\/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine","volume":"25","author":"Greco","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0175","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.vaccine.2004.11.017","article-title":"Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses","volume":"23","author":"Huang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0180","first-page":"42","article-title":"Production of rotavirus-like particles in","volume":"19","author":"Fruit","year":"2006","journal-title":"Tomato"},{"key":"10.1016\/j.nbt.2017.07.010_bib0185","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.vaccine.2009.01.014","article-title":"Refining HPV 16 L1 purification from E. coli: reducing endotoxin contaminations and their impact on immunogenicity","volume":"27","author":"Sch\u00e4dlich","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0190","doi-asserted-by":"crossref","first-page":"12803","DOI":"10.1016\/S0021-9258(17)38948-2","article-title":"Polyoma virus major capsid protein, VP1: Purification after high level expression in Escherichia coli","volume":"260","author":"Leavitt","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nbt.2017.07.010_bib0195","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.febslet.2004.09.009","article-title":"Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system","volume":"576","author":"Mortola","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nbt.2017.07.010_bib0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-59745-457-5_14","article-title":"Virus-like particle and viral vector production using the baculovirus expression vector system\/insect cell system: adeno-associated virus-based products","volume":"388","author":"Aucoin","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0205","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00705-005-0517-x","article-title":"Generation of recombinant Norovirus-like particles (VLP) in the human endothelial kidney cell line 293T","volume":"150","author":"Taube","year":"2005","journal-title":"Arch Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0210","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1046-5928(03)00011-1","article-title":"Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line","volume":"29","author":"Holzer","year":"2003","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.nbt.2017.07.010_bib0215","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1128\/JVI.77.16.8702-8711.2003","article-title":"Oral immunogenicity of human papillomavirus-like particles expressed in potato","volume":"77","author":"Warzecha","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0220","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","article-title":"Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice","volume":"24","author":"Huang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2006.03.021","article-title":"Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies","volume":"351","author":"Ye","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.nbt.2017.07.010_bib0230","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/bit.25503","article-title":"Extended gene expression by medium exchange and repeated transient transfection for recombinant protein production enhancement","volume":"112","author":"Cervera","year":"2015","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.nbt.2017.07.010_bib0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00253-009-2422-9","article-title":"Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology","volume":"86","author":"Eibl","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Francis","year":"1995","journal-title":"Annu Revi Immunol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0245","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.patbio.2010.01.006","article-title":"Hepatitis B vaccines: protective efficacy and therapeutic potential","volume":"58","author":"Michel","year":"2010","journal-title":"Pathol Biol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0250","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/281646a0","article-title":"Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli","volume":"281","author":"Galibert","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2017.07.010_bib0255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jchromb.2006.03.064","article-title":"Molecular characterization of recombinant Hepatitis B surface antigen from Chinese hamster ovary and Hansenula polymorpha cells by high-performance size exclusion chromatography and multi-angle laser light scattering","volume":"838","author":"Zhou","year":"2006","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.nbt.2017.07.010_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0047492","article-title":"Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses","volume":"7","author":"Chua","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbt.2017.07.010_bib0265","doi-asserted-by":"crossref","first-page":"h4067","DOI":"10.1136\/bmj.h4067","article-title":"European Medicines Agency approves first malaria vaccine","volume":"351","author":"Hawkes","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.nbt.2017.07.010_bib0270","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1015-1015","article-title":"Landmark green light for Mosquirix malaria vaccine","volume":"33","author":"Morrison","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0275","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nbt.2017.07.010_bib0280","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/hv.5.10.9518","article-title":"Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18\u201345 years","volume":"5","author":"Einstein","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.nbt.2017.07.010_bib0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.vaccine.2006.05.123","article-title":"Chapter 17: Second generation HPV vaccines to prevent cervical cancer","volume":"24","author":"Schiller","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0290","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","article-title":"Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin","volume":"25","author":"Bright","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.copbio.2015.12.007","article-title":"Molecular pharming-VLPs made in plants","volume":"37","author":"Marsian","year":"2016","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0300","series-title":"Kra H. HIV-1 Assembly, Budding, and Maturation","author":"Sundquist","year":"2015"},{"key":"10.1016\/j.nbt.2017.07.010_bib0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rmv.449","article-title":"Virus-like particles as HIV-1 vaccines","volume":"15","author":"Doan","year":"2005","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0310","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0264-410X(94)00061-Q","article-title":"Immunogenicity of the yeast recombinant p17 p24:Ty virus-like particles (p24-VLP) in healthy volunteers","volume":"13","author":"Weber","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0315","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s11427-011-4244-0","article-title":"Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine","volume":"54","author":"Zhang","year":"2011","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.nbt.2017.07.010_bib0320","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1016\/j.vaccine.2011.05.004","article-title":"HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line","volume":"29","author":"Tagliamonte","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nbt.2017.07.010_bib0325","first-page":"49","article-title":"Human parvoviru B19: a review","volume":"60","author":"Rogo","year":"2014","journal-title":"Acta Virol"},{"key":"10.1016\/j.nbt.2017.07.010_bib0330","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/erv.09.163","article-title":"Norwalk virus-like particles as vaccines","volume":"9","author":"Herbst-Kralovetz","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nbt.2017.07.010_bib0335","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2004.04.111","article-title":"Assembly of human severe acute respiratory syndrome coronavirus-like particles","volume":"318","author":"Ho","year":"2004","journal-title":"Biochem Biophys Res Commun"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678416325511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678416325511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:01:24Z","timestamp":1761732084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678416325511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":67,"alternative-id":["S1871678416325511"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2017.07.010","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production of virus-like particles for vaccines","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2017.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}